JERUSALEM, Oct. 24, 2017 /PRNewswire/ -- IDenta Corp. (OTC: IDTA), a worldwide leader in the development of proprietaryon-site drug, drug precursor and explosive detection kits, today announced the signing of a contract with the US company, Pro-gard. Pro-gard will function as a distributor for the entire US law enforcement market. Pro-gard was founded over fifty years
Amichai Glattstein, COO of IDenta: "We are very excited about our new partnership in the US market for law enforcement customers. We have found a company which meets our needs; a company with high standards and long experience. The cooperation between the companies has been excellent and together, we are looking forward to the launch of new technology in 2018.
About IDenta Corp. Since 2002, IDenta Corporation and its subsidiary IDenta Ltd has been recognized as a worldwide leader in the development of proprietary on-site drug, precursor of drug and explosive detection kits. IDenta develops, manufactures and distributes revolutionary products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Safe Harbor Statement Some of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Company Contact Information:Amichai Glattstein, COOTel: +972-2-5872220E: email@example.com
Investor Relations Contact:Ehud Helft/Gavriel FrohweinTel: +1-646-688-3559E: firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/identa-corp-contracts-with-us-distribution-partner-for-law-enforcement-market-300542052.html
SOURCE IDenta Corp.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All